Strides Shashun’s arm acquires Amneal Pharmaceuticals in Australia

01 Sep 2017 Evaluate

Strides Shashun’s arm Arrow Pharmaceuticals has acquired the Australian operations of Amneal Pharmaceuticals. The acquisition would accelerate Arrow’s market reach and will help in attaining a leadership position in the Australian generics market. Arrow Pharmaceuticals, Australia is a subsidiary of Strides Pharma Global, Singapore, which in-turn is a wholly owned subsidiary of Strides Shashun.

Under the terms of the agreement, Arrow Pharmaceuticals will acquire 100% of the issued capital of Amneal Pharmaceutical, Australia. Arrow will incur an amount of AUD 17 million towards consideration, working capital and other estimated acquisition and integration related costs. The definitive agreement was entered into on August 31, 2017 and is effective immediately.

Strides Shasun (formerly known as Strides Arcolab) is engaged in manufacturing, sale and export of pharmaceutical products. It offers general tablets, hard gelatin and soft gelatin capsules, sachets, potent drugs and semi-solids.


Strides Pharma Scien Share Price

877.75 9.25 (1.07%)
16-Dec-2025 11:46 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1788.20
Dr. Reddys Lab 1275.00
Cipla 1506.60
Zydus Lifesciences 922.05
Lupin 2091.20
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×